0.465
price up icon1.06%   0.0049
after-market After Hours: .45 -0.015 -3.23%
loading

Acurx Pharmaceuticals Inc Stock (ACXP) Latest News

pulisher
Mar 11, 2025

Acurx Pharmaceuticals (ACXP) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Acurx Pharmaceuticals Announces Closing of $1.1 Million Registered Direct Offering -March 10, 2025 at 05:37 pm EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Acurx Raises $1.1M in Direct Offering to Advance Antibiotics Pipeline - StockTitan

Mar 10, 2025
pulisher
Mar 07, 2025

Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Results - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30% - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Acurx Pharmaceuticals Launches $1.1 Million Registered Direct Offering; Shares Fall -March 07, 2025 at 10:07 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Nasdaq Gains 100 Points; US Economy Adds Fewer Jobs Than Projected - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering -March 07, 2025 at 08:14 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Can This $1.1M Funding Keep Acurx's Antibiotic Development on Track? - StockTitan

Mar 07, 2025
pulisher
Mar 05, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Decrease in Short Interest - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

ACXP stock touches 52-week low at $0.66 amid market challenges - Investing.com

Mar 04, 2025
pulisher
Mar 03, 2025

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics - Yahoo Finance

Mar 03, 2025
pulisher
Feb 28, 2025

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

What's Next for Acurx's Antibiotic Pipeline? March Earnings Call Will Reveal Development Progress - StockTitan

Feb 28, 2025
pulisher
Feb 27, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 27, 2025
pulisher
Feb 24, 2025

Acurx’s ibezapolstat shows selective bacterial targeting By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Pharmaceuticals Advances To Phase 3 Trials For C. Difficile Infection, Stock Down - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the - Digital More

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx's ibezapolstat shows selective bacterial targeting By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx's ibezapolstat shows selective bacterial targeting - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI - Longview News-Journal

Feb 24, 2025
pulisher
Feb 24, 2025

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative… - Informazione.it

Feb 24, 2025
pulisher
Feb 20, 2025

ACXP stock touches 52-week low at $0.67 amid market challenges - Investing.com UK

Feb 20, 2025
pulisher
Feb 19, 2025

Acurx Pharmaceuticals secures Japanese patent for antibiotics By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Acurx Pharmaceuticals secures Japanese patent for antibiotics - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Dual Victory for Acurx: Japanese Patent Grant Follows EMA's Green Light for Phase 3 Antibiotic Trial - StockTitan

Feb 19, 2025
pulisher
Feb 15, 2025

New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming - StreetInsider.com

Feb 15, 2025
pulisher
Feb 13, 2025

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Drops By 52.2% - Defense World

Feb 13, 2025
pulisher
Feb 02, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Decline in Short Interest - Armenian Reporter

Feb 02, 2025
pulisher
Jan 31, 2025

Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares -January 31, 2025 at 05:06 pm EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update - Defense World

Jan 31, 2025
pulisher
Jan 28, 2025

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH) - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 14, 2025

Geode Capital Management LLC Increases Stake in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Acurx Pharmaceuticals Inc (ACXP) - SETE News

Jan 13, 2025
pulisher
Jan 12, 2025

HC Wainwright Reaffirms Buy Rating for Acurx Pharmaceuticals (NASDAQ:ACXP) - Defense World

Jan 12, 2025
pulisher
Jan 09, 2025

Acurx Pharmaceuticals (NASDAQ: ACXP) Announces $2.5 Million Registered Direct Offering - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

Acurx pharmaceuticals director Carl Sailer acquires shares worth $25,000 - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Acurx pharmaceuticals director Joseph Scodari acquires $25,000 in stock - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Acurx pharmaceuticals director Carl Sailer acquires shares worth $25,000 By Investing.com - Investing.com UK

Jan 08, 2025
pulisher
Jan 08, 2025

Acurx Pharmaceuticals director buys $9,999 in common stock - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Acurx Pharmaceuticals director Robert DeLucca buys $49,999 in stock By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 08, 2025

ACXP stock touches 52-week low at $0.72 amid market challenges - Investing.com Canada

Jan 08, 2025
pulisher
Jan 07, 2025

Acurx Pharmaceuticals Secures $2.5M Financing Through Direct Offering and Warrant Placement - StockTitan

Jan 07, 2025
pulisher
Jan 07, 2025

Form 424B5 Acurx Pharmaceuticals, - StreetInsider.com

Jan 07, 2025
pulisher
Jan 07, 2025

SEC Form 424B5 filed by Acurx Pharmaceuticals Inc. - Quantisnow

Jan 07, 2025
pulisher
Jan 07, 2025

Acurx to sell 2.46M shares at $1.015 in registered direct offering - MSN

Jan 07, 2025
pulisher
Jan 06, 2025

Acurx gains EMA support for ibezapolstat Phase 3 trial By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Acurx Pharmaceuticals announces $2.5 million registered direct offering - MSN

Jan 06, 2025
pulisher
Jan 06, 2025

Acurx gains EMA support for ibezapolstat Phase 3 trial - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Acurx's Ibezapolstat Secures EMA Backing for Phase 3 C. Difficile Treatment Program - StockTitan

Jan 06, 2025
pulisher
Jan 03, 2025

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? - Yahoo Finance

Jan 03, 2025
pulisher
Dec 31, 2024

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Increase in Short Interest - Defense World

Dec 31, 2024
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):